Viral Encephalitis Treatment & Management
- Author: Francisco de Assis Aquino Gondim, MD, MSc, PhD; more...
Approach Considerations
Medical care should be devoted to appropriate management of the airway, bladder function, fluid and electrolyte balance, nutrition, prevention of bedsores, secondary pulmonary infection, and hyperpyrexia. A multidisciplinary approach must be instituted as early as possible to start physical and cognitive rehabilitation and to minimize cognitive problems and long-term sequelae. Care in an intensive care unit (ICU) setting may be required, especially if seizure activity or increased intracranial pressure (ICP) is present.[35]
Delayed diagnosis of herpes simplex encephalitis (HSE) increases morbidity and mortality rates; failure to diagnose and treat early could result in litigation. With the wide availability of effective therapy, initiating antiviral treatment before a definitive diagnosis of HSE encephalitis (ie, during the workup) is now common practice.
The use of corticosteroids as an adjunctive therapy for viral encephalitis is controversial and currently being evaluated in a large clinical trial.
See the following for complete information on these topics:
Antiviral Therapy
Pharmacotherapy for HSE consists of acyclovir and vidarabine. Outcome is improved with either agent, but acyclovir is more effective and less toxic. Even if the final diagnosis of HSE has not been established, intravenous (IV) acyclovir should be initiated immediately. Acyclovir is also the drug of choice for varicella-zoster virus (VZV) encephalitis, although ganciclovir is also considered an alternative option.
Ganciclovir has been used for cytomegalovirus (CMV) encephalitis, but with therapeutic failures; consequently, the optimal therapy for CMV encephalitis is unknown. Ganciclovir combined with foscarnet has been used in the treatment of patients infected with HIV.
No specific treatment is available for the arbovirus encephalitides. Ribavirin seems to be effective for Lassa fever; its efficacy in other viral infections is being evaluated. Intraventricular ribavirin has been associated with clinical improvement in 4 patients with subacute sclerosing panencephalitis (SSPE) and apparently reduced mortality in an open-label trial in patients with Nipah virus encephalitis.
Results from a small series suggested that interferon alfa-2b reduced the severity and duration of the complications of St Louis encephalitis virus meningoencephalitis.[36]
Because specific therapy for encephalitis is limited and because potentially serious sequelae (or death) may result from HSE, early treatment with acyclovir should be started as soon as possible in all patients with suspected viral encephalitis, pending the results of diagnostic studies. Once an etiologic agent of the encephalitis is eventually identified, therapy should be targeted to that agent (if available).
Other antibacterial treatments (eg, for bacterial meningitis) should be administered on the basis of epidemiological and clinical factors or given until the diagnosis of bacterial meningitis is excluded. Doxycycline should be added if there is suspicion of rickettsial or ehrlichial infection during the appropriate season.
Management of Increased Intracranial Pressure
Increased ICP should be managed in the ICU setting with head elevation, gentle diuresis, mannitol, and hyperventilation. Surgical decompression may be necessary if there is impending uncal herniation or increased ICP that is refractory to medical management. Controlled studies are lacking, but there is some evidence that patients with life-threatening cerebral edema may benefit from craniectomy or other approaches to lower the increased ICP in neurocritical care units.[37]
Management of Seizures
Encephalitis causes a wide range of behavioral manifestations with limbic and frontal syndromes that can be difficult to distinguish from partial seizures.[38] Seizure activity can be closely observed using electroencephalography (EEG), and the threshold for administering temporary anticonvulsant therapy should be low.
Phenytoin and valproic acid can be administered intravenously. Phenytoin and carbamazepine can be administered when oral or intragastric drug administration is possible. Benzodiazepines are also important when used to abort status epilepticus.
If seizure activity persists after the acute phase, patients may need long-term anticonvulsant therapy. Accordingly, additional therapy may be necessary for extrapyramidal, motor, and behavioral complications.
Prevention
Surveillance is important to predict outbreaks of arboviral infections. Mosquitoes can be sampled to estimate infection rates in mosquito pools. Protective clothing and repellents are useful in the prevention of arthropod bites. Avoidance of outdoor activities is also useful. Prompt removal of ticks may decrease the risk of transmission of a tick-borne virus.
Effective preventive measures include removing water-holding containers and discarded tires. Insecticides may be useful in the emergency control of infected mosquitoes. Control of the mosquito vector has been used with apparently good results in several recent epidemics.
Vaccines are available for eastern equine encephalitis (EEE), western equine encephalitis (WEE), and Venezuelan equine encephalitis (VEE) in horses. A live attenuated vaccine (TC-83) has been used to protect laboratory and field workers from the virus that causes VEE. Vaccines have also been developed for Japanese B virus encephalitis (JE) and tick-borne encephalitis.
Killed virus vaccines have been produced experimentally for several arboviruses. A live-attenuated Japanese B vaccine (SA 14-14-2) has been used widely in Asia. Since 1989, 120 million children have been immunized, and a recent report has demonstrated the efficacy of a single dose in preventing Japanese encephalitis (JE) when administered only days or weeks before exposure to infection. The only internationally licensed JE virus vaccine is a formalin-inactivated vaccine.
Limited use (eg, in exposed laboratory workers) has been made of vaccines for VEE and tick-borne viral encephalitis. Passive immunization of laboratory workers exposed to a known virus in a laboratory accident has been accomplished with immune (human) serum or gamma globulin.
Despite control efforts and disease surveillance, the 1999 outbreak of West Nile virus in New York, with subsequent spread to other states in the United States, showed that different viruses may be spread in the Western hemisphere because of increased international travel and trade. Massive culling of pigs in Malaysia decreased the incidence of Nipah virus infection.
Consultations and Additional Care
Encephalitis is a neurological emergency. Consultation with a neurologist is recommended. Consultation with a neurosurgeon is helpful if a brain biopsy is considered. Consultation with an infectious disease specialist is also appropriate.
Given the high likelihood of long-term need for cognitive rehabilitation and physical rehabilitation, especially in moderately severe and severe forms of encephalitis, establishing a multidisciplinary approach early in the disease course is appropriate. A multidisciplinary approach includes consultations with physical, occupational, and speech therapists.
No dietary restrictions are necessary. The infectious process, especially with the presence of fever, increases nutritional requirements. Early assessment by a speech therapist and a dietitian helps prevent further body wasting and detects early behavioral manifestations that prevent adequate nutritional intake, such as placidity, apraxia, dysphagia, or agitation.
Gendelman HE, Persidsky Y. Infections of the nervous system. Lancet Neurol. 2005;4:12-3. [Medline].
Kennedy PG. Viral encephalitis. J Neurol. 2005;Epub ahead of print:march 11. [Medline].
Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J Virol. Jun 2008;82(11):5212-9. [Medline].
Sarkari NB, Thacker AK, Barthwal SP, et al. Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol. Jun 17 2011;[Medline].
Lee N, Wong CK, Chan PK, Lindegardh N, White NJ, Hayden FG, et al. Acute encephalopathy associated with influenza A infection in adults. Emerg Infect Dis. Jan 2010;16(1):139-42. [Medline].
Lopez W. West Nile virus in New York City. Am J Public Health. Aug 2002;92(8):1218-21. [Medline].
Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. Jul 28 2001;358(9278):261-4. [Medline].
Domingues RB, Teixeira AL. Management of acute viral encephalitis in Brazil. Braz J Infect Dis. Dec 2009;13(6):433-9. [Medline].
Muzaffar J, Venkata Krishnan P, Gupta N, Kar P. Dengue encephalitis: why we need to identify this entity in a dengue-prone region. Singapore Med J. Nov 2006;47(11):975-7. [Medline].
Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. May 31 2008;371(9627):1861-71. [Medline].
Sokol DK, Kleiman MB, Garg BP. LaCrosse viral encephalitis mimics herpes simplex viral encephalitis. Pediatr Neurol. Nov 2001;25(5):413-5. [Medline].
Hsu VP, Hossain MJ, Parashar UD, et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis. Dec 2004;10(12):2082-7. [Medline].
Casolari S, Briganti E, Zanotti M, Zauli T, Nicoletti L, Magurano F, et al. A fatal case of encephalitis associated with Chikungunya virus infection. Scand J Infect Dis. Sep 26 2008;1-2. [Medline].
John TJ. Chandipura virus, encephalitis, and epidemic brain attack in India. Lancet. 2004;364:2175. [Medline].
Sejvar JJ. The evolving epidemiology of viral encephalitis. Curr Opin Neurol. 2006;19:350-7. [Medline].
Rantalaiho T, Färkkilä M, Vaheri A, Koskiniemi M. Acute encephalitis from 1967 to 1991. J Neurol Sci. Mar 1 2001;184(2):169-77. [Medline].
Kullnat MW, Morse RP. Choreoathetosis after herpes simplex encephalitis with basal ganglia involvement on MRI. Pediatrics. Apr 2008;121(4):e1003-7. [Medline].
Rautonen J, Koskiniemi M, Vaheri A. Prognostic factors in childhood acute encephalitis. Pediatr Infect Dis J. Jun 1991;10(6):441-6. [Medline].
Lancman ME, Morris HH. Epilepsy after central nervous system infection: clinical characteristics and outcome after epilepsy surgery. Epilepsy Res. Nov 1996;25(3):285-90. [Medline].
Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia. Aug 2008;49 Suppl 6:13-8. [Medline].
Sato S, Kumada S, Koji T, Okaniwa M. Reversible frontal lobe syndrome associated with influenza virus infection in children. Pediatr Neurol. Apr 2000;22(4):318-21. [Medline].
Webster RI, Hazelton B, Suleiman J, Macartney K, Kesson A, Dale RC. Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. Neurology. Mar 30 2010;74(13):1077-8. [Medline].
Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol. Sep 2006;60(3):286-300. [Medline].
Debiasi RL, Tyler KL. West Nile virus meningoencephalitis. Nat Clin Pract Neurol. May 2006;2(5):264-75. [Medline].
Sejvar JJ, Davis LE, Szabados E, Jackson AC. Delayed-onset and recurrent limb weakness associated with West Nile virus infection. J Neurovirol. Feb 2010;16(1):93-100. [Medline].
Kumar R, Tripathi S, Tambe JJ, Arora V, Srivastava A, Nag VL. Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue. J Neurol Sci. Jun 15 2008;269(1-2):41-8. [Medline].
De Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 352:686-91. [Medline].
Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, Webster R, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A. Aug 18 2009;106(33):14063-8. [Medline]. [Full Text].
Ng BY, Lim CC, Yeoh A, Lee WL. Neuropsychiatric sequelae of Nipah virus encephalitis. J Neuropsychiatry Clin Neurosci. 2004;16:500-4. [Medline].
Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet. Mar 25 2000;355(9209):1053-9. [Medline].
Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. Mar 3 2010;[Medline].
Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, Castro MJ, Faria LC, Peralta JM. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology. Oct 27 2009;73(17):1413-7. [Medline].
Oguz KK, Celebi A, Anlar B. MR imaging, diffusion-weighted imaging and MR spectroscopy findings in acute rapidly progressive subacute sclerosing panencephalitis. Brain Dev. 2006;Epub ahead of print:[Medline].
Kalita J, Misra UK. EEG in Japanese encephalitis: a clinico-radiological correlation. Electroencephalogr Clin Neurophysiol. Mar 1998;106(3):238-43. [Medline].
Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. Aug 1 2008;47(3):303-27. [Medline].
Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. Effect of interferon-α2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis. 2004;2004:1084-7.
Hall WA, Truwit CL. The surgical management of infections involving the cerebrum. Neurosurgery. Feb 2008;62 Suppl 2:519-530; discussion 530-1. [Medline].
Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. Sep 1988;38(9):1407-10. [Medline].
Tsai CK, Lai YH, Yang FC, Chen CY, Peng GS. Clinical and radiologic manifestations of H1N1 virus infection associated with neurological complications: a case report. Neurologist. Jul 2011;17(4):228-31. [Medline].
| Virus | Receptor | Abbreviation/Synonym | Function |
| Measles virus | Membrane cofactor protein | CD46 | Regulates complement and prevents activation of complement on autologous cells |
| Poliovirus | CD155 | hPVR/CD155 | Expressed on primary human monocytes; supports poliovirus replication in vivo |
| HSV | Heparan sulfate | None | Cell surface proteoglycans |
| Herpesvirus entry mediator A | Hve A, HVEM | TNF receptor superfamily | |
| Herpesvirus entry mediator B | Hve B, Human nectin-2, or Prr2alpha-Hve B | Participate in organization of epithelial and endothelial junctions | |
| Herpesvirus entry mediator C | Hve C, nectin1delta, or Prr1-Hve C | Immunoglobulin superfamily | |
| TNFSF14 | hTNFSF14/HVEM-L | TNF receptor superfamily | |
| Rabies virus | Nicotinic AChR (a-bungarotoxin binding site) | AChR | Nicotinic AChR |
| NCAM | NCAM, CD56, D2CAM, Leu19, or NKH-1 | Cell adhesion glycoprotein of immunoglobulin superfamily | |
| NGFR | NGFR | NGFR | |
| p75 neurotrophin receptor (p75NTR) | p75NTR | ||
| HIV-1 | CD4 | CD4 | T lymphocyte protein with helper or inducer function in immune system |
| CCR3 | CCR3 | Chemotactic activity | |
| CCR5 | CCR5 | Coreceptor for macrophage-tropic strain | |
| CCR6 | CCR65 | Chemotactic activity | |
| CXCR4 | CXCR4 | Coreceptor for CD4 | |
| JC virus | N-linked glycoprotein with alpha 2-6 sialic acid | N-linked glycoprotein | Unknown |
| Japanese B virus[4] | Protein GRP78 | --- | ER-stress response protein |
| AChR—acetylcetylcholine receptor; CCR—chemokine receptor; HSV—herpes simplex virus; NCAM—neural cell adhesion molecule; NGFR—nerve growth factor receptor; TNF—tumor necrosis factor. | |||
| Virus (Family) | Viral Structure | Transmission | Mortality | Specific Clinical Patterns | Sequelae | Season |
| HSV (herpesvirus) | ds DNA | Unknown | 70% if untreated | Rare forms: subacute, psychiatric, opercular, recurrent meningitis HSV-1: brainstem; HSV-2: myelitis | Common | All year |
| VZV (herpesvirus) | ds DNA | Direct contact (air), highly contagious | Variable; low in children | Rash, encephalitis in 0.1-0.2% of children with chickenpox; cerebellar ataxia (cerebellitis) | Adults worse; cerebellitis good | Late winter, spring |
| Influenza virus (orthomyxovirus) | ss RNA | Direct contact (air), highly contagious | Unknown | Reversible frontal syndrome in children; Guillain-Barré, myelitis | Parkinsonism (encephalitis lethargica) | Usually winter |
| Enteroviruses (picornavirus) | ss RNA | Fecal-oral route | Low; high for enterovirus 71 | Herpangina; hand, foot, mouth disease; enterovirus 71 causes rhombencephalitis | Mild, except for enterovirus 71 | Summer, fall; tropics: no season |
| Rabies virus (rhabdovirus) | ss RNA | Dogs, wild animals (eg, fox, wolf, skunk) | Virtually 100% | Paresthesias; confusion, spasms, hydrophobia; brainstem features | Mortality virtually 100% | All year |
| ds—double strand; HSV—herpes simplex virus; ss—single strand; VZV—varicella-zoster virus. | ||||||
| Virus (Family) | Viral Structure | Transmission | Mortality | Specific Clinical Patterns | Sequelae | Season |
| Lymphocytic choriomeningitis virus (arenavirus) | ss RNA | Rodents | Low (< 1%) | Progressive fever and myalgia; orchitis; aseptic meningitis; leukopenia, thrombocytopenia | Rare | More in winter |
| Lassa virus (arenavirus) | ss RNA | Rodents | 15% | Multisystem disease; proteinuria | Deafness (one third) | All year |
| Mumps virus (paramyxovirus) | ss RNA | Direct contact (air), highly contagious | Low | Parotitis, pancreatitis, orchitis, aseptic meningitis | Frequent sequelae | Winter and spring |
| Measles virus (paramyxovirus) | ss RNA | Direct contact (air), highly contagious | 10% | Characteristic rash; frequent EEG changes; myelitis | Frequent: mental retardation, seizures, SSPE | Winter and spring |
| Nipah virus (paramyxovirus) | ss RNA | Pigs; bats | 40% | Brainstem or cerebellar signs; segmental myoclonus, dysautonomia | SSPE-like syndrome? | All year |
| ds—double strand; EEG—electroencephalographic; ss—single strand; SSPE—subacute sclerosing panencephalitis. | ||||||
| Virus (Family) | Vector | Reservoir | Mortality | Specific Clinical Patterns | Sequelae | Season |
| Eastern equine virus (alphavirus) | Aedes sollicitans | Birds | 35% | Severe, rapid progression | Common, especially in children | June to October |
| Western equine virus (alphavirus) | Culex tarsalis | Birds | 10% | Classic encephalitis | Moderate in infants; low in others | July to October |
| Venezuelan equine encephalitis virus (alphavirus) | Mosquito species | Horses, small mammals | ~ 0.4 % | Low rate (4%) of CNS involvement | Mild | Rainy season |
| St Louis encephalitis virus (flavivirus) | Culex pipiens,C tarsalis | Birds | 2% in young people; 20% in elderly people | SIADH | More in elderly people | August to October |
| Japanese encephalitis virus (flavivirus) | Culex taeniorhynchus | Birds | 33% (50% in elderly people) | Extrapyramidal features | 50% neuro psychiatric; parkinsonism | Summer |
| West Nile virus (flavivirus) | Culex,Aedes spp | Birds | In US: 12% (elderly people only) | Motor or brainstem involvement | Usually not prominent | Summer |
| Far East encephalitis virus (flavivirus) | Ixodes persulcatus (tick) | Small mammals, birds | 20% | Epilepsia partialis continua | Frequent; residual weakness | Spring to early summer |
| Central European encephalitis virus (flavivirus) | Ixodes ricinus (tick) | Small mammals, birds | Less common than in Far East | Limb-girdle paralysis (spine/medulla) | Less common than in Far East | April to October |
| Powassan virus (flavivirus) | Ixodes cookei (tick) | Small mammals, birds | High | Severe encephalitis | Common (50%) | May to December |
| Dengue virus (flavivirus) | Aedes spp | Mosquitoes | Low, except hemorrhagic | Flulike syndrome; rare CNS involvement | Mild, except for hemorrhagic | Rainy season |
| La Crosse virus (bunyavirus) | Aedes triseriatus | Small mammals | Low (< 1%) | Mild, primarily in children | Mild; seizures | Summer |
| Colorado tick fever virus (orbivirus) | Dermacentor andersoni (tick) | Small mammals | Low | Mild | ||
| CNS—central nervous system; SIADH—syndrome of inappropriate antidiuretic hormone secretion. | ||||||

